ZENDAL

MTBVAC

Vaccines
Cancer
MTBVAC vaccine is based on a genetically attenuated strain of a clinical isolate of M. tuberculosis manufactured by BIOFABRI (Zendal Corp.). MTBVAC is in Phase 3 in newborn infants in South Africa, Senegal and Madagascar and finished Phase2a in adults
3Phase III, 2Phase II, 1Phase I, 2Regulatory Preclinical, 1Non Regulatory Preclinical